{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T06:43:18Z","timestamp":1782456198745,"version":"3.54.5"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008269","name":"Michigan Institute for Clinical and Health Research","doi-asserted-by":"publisher","award":["UL1TR002240"],"award-info":[{"award-number":["UL1TR002240"]}],"id":[{"id":"10.13039\/100008269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016526","name":"George M. O'Brien Michigan Kidney Translational Core Center","doi-asserted-by":"publisher","award":["P30 DK081943"],"award-info":[{"award-number":["P30 DK081943"]}],"id":[{"id":"10.13039\/100016526","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["K23 DK 125529"],"award-info":[{"award-number":["K23 DK 125529"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01 DK 100449"],"award-info":[{"award-number":["R01 DK 100449"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01 DK 102643"],"award-info":[{"award-number":["R01 DK 102643"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01 DK 102643"],"award-info":[{"award-number":["R01 DK 102643"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Increasing evidence suggests that single in kidney states (e.g., kidney transplantation and living donation) progressive glomerulosclerosis limits kidney lifespan. Modeling shows that post-nephrectomy compensatory glomerular volume (GV) increase drives podocyte depletion and hypertrophic stress resulting in proteinuria and glomerulosclerosis, implying that GV increase could serve as a therapeutic target to prevent progression. In this report we examine how Angiotensin Converting Enzyme inhibition (ACEi), started before uninephrectomy can reduce compensatory GV increase in wild-type Fischer344 rats. An unbiased computer-assisted method was used for morphometric analysis. Urine Insulin-like growth factor-1 (IGF-1), the major diver of body and kidney growth, was used as a readout. In long-term (40-week) studies of uni-nephrectomized versus sham-nephrectomized rats a 2.2-fold increase in GV was associated with reduced podocyte density, increased proteinuria and glomerulosclerosis. Compensatory GV increase was largely prevented by ACEi started a week before but not after uni-nephrectomy with no measurable impact on long-term eGFR. Similarly, in short-term (14-day) studies, ACEi started a week before uni-nephrectomy reduced both GV increase and urine IGF-1 excretion. Thus, timing of ACEi in relation to uni-nephrectomy had significant impact on post-nephrectomy \u201ccompensatory\u201d glomerular growth and outcomes that could potentially be used to improve kidney transplantation and live kidney donation outcomes.<\/jats:p>","DOI":"10.1038\/s41598-021-99124-z","type":"journal-article","created":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T11:02:54Z","timestamp":1633086174000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Critical timing of ACEi initiation prevents compensatory glomerular hypertrophy in the remaining single kidney"],"prefix":"10.1038","volume":"11","author":[{"given":"Abhijit S.","family":"Naik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su Q.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahboob","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jawad","family":"Aqeel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher L.","family":"O\u2019Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelyn E.","family":"Wiggins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Bitzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger C.","family":"Wiggins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,1]]},"reference":[{"key":"99124_CR1","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1038\/ki.1996.265","volume":"49","author":"BM Brenner","year":"1996","unstructured":"Brenner, B. M., Lawler, E. V. & Mackenzie, H. S. The hyperfiltration theory: A paradigm shift in nephrology. Kidney Int. 49, 1774\u20131777. https:\/\/doi.org\/10.1038\/ki.1996.265 (1996).","journal-title":"Kidney Int."},{"key":"99124_CR2","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/0272-6386(93)70097-i","volume":"21","author":"BM Brenner","year":"1993","unstructured":"Brenner, B. M. & Milford, E. L. Nephron underdosing: A programmed cause of chronic renal allograft failure. Am. J. Kidney Dis. 21, 66\u201372. https:\/\/doi.org\/10.1016\/0272-6386(93)70097-i (1993).","journal-title":"Am. J. Kidney Dis."},{"key":"99124_CR3","doi-asserted-by":"publisher","first-page":"F85","DOI":"10.1152\/ajprenal.1981.241.1.F85","volume":"241","author":"TH Hostetter","year":"1981","unstructured":"Hostetter, T. H., Olson, J. L., Rennke, H. G., Venkatachalam, M. A. & Brenner, B. M. Hyperfiltration in remnant nephrons: A potentially adverse response to renal ablation. Am. J. Physiol. 241, F85-93. https:\/\/doi.org\/10.1152\/ajprenal.1981.241.1.F85 (1981).","journal-title":"Am. J. Physiol."},{"key":"99124_CR4","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.1681\/ASN.2020040449","volume":"31","author":"A Denic","year":"2020","unstructured":"Denic, A. et al. Larger nephron size and nephrosclerosis predict progressive CKD and mortality after radical nephrectomy for tumor and independent of kidney function. J. Am. Soc. Nephrol. 31, 2642\u20132652. https:\/\/doi.org\/10.1681\/ASN.2020040449 (2020).","journal-title":"J. Am. Soc. Nephrol."},{"key":"99124_CR5","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1001\/jama.2013.285141","volume":"311","author":"AD Muzaale","year":"2014","unstructured":"Muzaale, A. D. et al. Risk of end-stage renal disease following live kidney donation. JAMA 311, 579\u2013586. https:\/\/doi.org\/10.1001\/jama.2013.285141 (2014).","journal-title":"JAMA"},{"key":"99124_CR6","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJMoa1510491","volume":"374","author":"ME Grams","year":"2016","unstructured":"Grams, M. E. et al. Kidney-failure risk projection for the living kidney-donor candidate. N. Engl. J. Med. 374, 411\u2013421 (2016).","journal-title":"N. Engl. J. Med."},{"key":"99124_CR7","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1681\/ASN.2015091018","volume":"27","author":"HN Ibrahim","year":"2016","unstructured":"Ibrahim, H. N. et al. Renal function profile in white kidney donors: The first 4 decades. J. Am. Soc. Nephrol. 27, 2885\u20132893. https:\/\/doi.org\/10.1681\/ASN.2015091018 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"99124_CR8","doi-asserted-by":"publisher","first-page":"3540","DOI":"10.1111\/ajt.13917","volume":"16","author":"S Anjum","year":"2016","unstructured":"Anjum, S. et al. Patterns of end-stage renal disease caused by diabetes, hypertension, and glomerulonephritis in live kidney donors. Am. J. Transplant. 16, 3540\u20133547. https:\/\/doi.org\/10.1111\/ajt.13917 (2016).","journal-title":"Am. J. Transplant."},{"key":"99124_CR9","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1038\/ki.1984.112","volume":"25","author":"RM Hakim","year":"1984","unstructured":"Hakim, R. M., Goldszer, R. C. & Brenner, B. M. Hypertension and proteinuria: Long-term sequelae of uninephrectomy in humans. Kidney Int. 25, 930\u2013936. https:\/\/doi.org\/10.1038\/ki.1984.112 (1984).","journal-title":"Kidney Int."},{"key":"99124_CR10","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1038\/sj.ki.5001819","volume":"70","author":"AX Garg","year":"2006","unstructured":"Garg, A. X. et al. Proteinuria and reduced kidney function in living kidney donors: A systematic review, meta-analysis, and meta-regression. Kidney Int. 70, 1801\u20131810. https:\/\/doi.org\/10.1038\/sj.ki.5001819 (2006).","journal-title":"Kidney Int."},{"key":"99124_CR11","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.86943","author":"AS Naik","year":"2016","unstructured":"Naik, A. S. et al. Quantitative podocyte parameters predict human native kidney and allograft half-lives. JCI Insight https:\/\/doi.org\/10.1172\/jci.insight.86943 (2016).","journal-title":"JCI Insight"},{"key":"99124_CR12","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1056\/NEJMoa020009","volume":"349","author":"BJ Nankivell","year":"2003","unstructured":"Nankivell, B. J. et al. The natural history of chronic allograft nephropathy. N. Engl. J. Med. 349, 2326\u20132333. https:\/\/doi.org\/10.1056\/NEJMoa020009 (2003).","journal-title":"N. Engl. J. Med."},{"key":"99124_CR13","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/ajt.14431","volume":"18","author":"MD Stegall","year":"2017","unstructured":"Stegall, M. D., Cornell, L. D., Park, W. D., Smith, B. H. & Cosio, F. G. Renal allograft histology at 10 years after transplantation in the tacrolimus era: Evidence of pervasive chronic injury. Am. J. Transplant. 18, 180\u2013188 (2017).","journal-title":"Am. J. Transplant."},{"key":"99124_CR14","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/j.1600-6143.2006.01672.x","volume":"7","author":"RJ Bosma","year":"2007","unstructured":"Bosma, R. J., Kwakernaak, A. J., van der Heide, J. J., de Jong, P. E. & Navis, G. J. Body mass index and glomerular hyperfiltration in renal transplant recipients: cross-sectional analysis and long-term impact. Am. J. Transplant. 7, 645\u2013652. https:\/\/doi.org\/10.1111\/j.1600-6143.2006.01672.x (2007).","journal-title":"Am. J. Transplant."},{"key":"99124_CR15","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1097\/01.asn.0000024564.22119.3d","volume":"13","author":"BL Kasiske","year":"2002","unstructured":"Kasiske, B. L., Snyder, J. J. & Gilbertson, D. Inadequate donor size in cadaver kidney transplantation. J. Am. Soc. Nephrol. 13, 2152\u20132159. https:\/\/doi.org\/10.1097\/01.asn.0000024564.22119.3d (2002).","journal-title":"J. Am. Soc. Nephrol."},{"key":"99124_CR16","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1681\/ASN.2009121296","volume":"21","author":"M Giral","year":"2010","unstructured":"Giral, M. et al. Kidney and recipient weight incompatibility reduces long-term graft survival. J. Am. Soc. Nephrol. 21, 1022\u20131029. https:\/\/doi.org\/10.1681\/ASN.2009121296 (2010).","journal-title":"J. Am. Soc. Nephrol."},{"key":"99124_CR17","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1681\/ASN.2014030287","volume":"26","author":"Y Yang","year":"2015","unstructured":"Yang, Y. et al. The two kidney to one kidney transition and transplant glomerulopathy: A podocyte perspective. J. Am. Soc. Nephrol. 26, 1450\u20131465. https:\/\/doi.org\/10.1681\/ASN.2014030287 (2015).","journal-title":"J. Am. Soc. Nephrol."},{"key":"99124_CR18","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1093\/ndt\/gfy350","volume":"34","author":"AS Naik","year":"2018","unstructured":"Naik, A. S. et al. Accelerated podocyte detachment early after kidney transplantation is related to long-term allograft loss of function. Nephrol. Dial. Transplant. 34, 1232\u20131239 (2018).","journal-title":"Nephrol. Dial. Transplant."},{"key":"99124_CR19","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1681\/ASN.2020101486","volume":"32","author":"K Haruhara","year":"2021","unstructured":"Haruhara, K. et al. Podometrics in Japanese living donor kidneys: Associations with nephron number, age, and hypertension. J. Am. Soc. Nephrol. 32, 1187\u20131199. https:\/\/doi.org\/10.1681\/ASN.2020101486 (2021).","journal-title":"J. Am. Soc. Nephrol."},{"key":"99124_CR20","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1111\/j.1600-6143.2007.01928.x","volume":"7","author":"S Hiremath","year":"2007","unstructured":"Hiremath, S., Fergusson, D., Doucette, S., Mulay, A. V. & Knoll, G. A. Renin angiotensin system blockade in kidney transplantation: A systematic review of the evidence. Am. J. Transplant. 7, 2350\u20132360. https:\/\/doi.org\/10.1111\/j.1600-6143.2007.01928.x (2007).","journal-title":"Am. J. Transplant."},{"key":"99124_CR21","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1111\/ajt.15225","volume":"19","author":"SM Cockfield","year":"2018","unstructured":"Cockfield, S. M. et al. Comparison of the effects of standard vs low-dose prolonged-release tacrolimus with or without ACEi\/ARB on the histology and function of renal allografts. Am. J. Transplant. 19, 1730\u20131744 (2018).","journal-title":"Am. J. Transplant."},{"key":"99124_CR22","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/ki.1989.35","volume":"35","author":"Y Yoshida","year":"1989","unstructured":"Yoshida, Y., Fogo, A. & Ichikawa, I. Glomerular hemodynamic changes vs. hypertrophy in experimental glomerular sclerosis. Kidney Int. 35, 654\u2013660 (1989).","journal-title":"Kidney Int."},{"key":"99124_CR23","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/ki.1991.200","volume":"40","author":"M Ikoma","year":"1991","unstructured":"Ikoma, M., Kawamura, T., Kakinuma, Y., Fogo, A. & Ichikawa, I. Cause of variable therapeutic efficiency of angiotensin converting enzyme inhibitor on glomerular lesions. Kidney Int. 40, 195\u2013202 (1991).","journal-title":"Kidney Int."},{"key":"99124_CR24","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/ki.1994.69","volume":"45","author":"R Tanaka","year":"1994","unstructured":"Tanaka, R., Kon, V., Yoshioka, T., Ichikawa, I. & Fogo, A. Angiotensin converting enzyme inhibitor modulates glomerular function and structure by distinct mechanisms. Kidney Int. 45, 537\u2013543 (1994).","journal-title":"Kidney Int."},{"key":"99124_CR25","doi-asserted-by":"publisher","first-page":"2931","DOI":"10.1681\/ASN.2017020174","volume":"28","author":"R Nishizono","year":"2017","unstructured":"Nishizono, R. et al. FSGS as an Adaptive response to growth-induced podocyte stress. J. Am. Soc. Nephrol. 28, 2931\u20132945. https:\/\/doi.org\/10.1681\/ASN.2017020174 (2017).","journal-title":"J. Am. Soc. Nephrol."},{"key":"99124_CR26","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1681\/ASN.2012030271","volume":"23","author":"A Fukuda","year":"2012","unstructured":"Fukuda, A. et al. Growth-dependent podocyte failure causes glomerulosclerosis. J. Am. Soc. Nephrol. 23, 1351\u20131363. https:\/\/doi.org\/10.1681\/ASN.2012030271 (2012).","journal-title":"J. Am. Soc. Nephrol."},{"key":"99124_CR27","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1681\/asn.2017060612","volume":"28","author":"VD D\u2019Agati","year":"2017","unstructured":"D\u2019Agati, V. D. Podocyte growing pains in adaptive FSGS. J. Am. Soc. Nephrol. 28, 2825\u20132827. https:\/\/doi.org\/10.1681\/asn.2017060612 (2017).","journal-title":"J. Am. Soc. Nephrol."},{"key":"99124_CR28","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1097\/01.asn.0000130563.67384.81","volume":"15","author":"DH Sigmon","year":"2004","unstructured":"Sigmon, D. H., Gonzalez-Feldman, E., Cavasin, M. A., Potter, D. L. & Beierwaltes, W. H. Role of nitric oxide in the renal hemodynamic response to unilateral nephrectomy. J. Am. Soc. Nephrol. 15, 1413\u20131420. https:\/\/doi.org\/10.1097\/01.asn.0000130563.67384.81 (2004).","journal-title":"J. Am. Soc. Nephrol."},{"key":"99124_CR29","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3389\/fendo.2018.00117","volume":"9","author":"JB Allard","year":"2018","unstructured":"Allard, J. B. & Duan, C. IGF-binding proteins: Why do they exist and why are there so many?. Front. Endocrinol. 9, 117 (2018).","journal-title":"Front. Endocrinol."},{"key":"99124_CR30","doi-asserted-by":"publisher","first-page":"T11","DOI":"10.1530\/JME-17-0254","volume":"61","author":"L Bach","year":"2018","unstructured":"Bach, L. 40 years of IGF1: IGF-binding proteins. J. Mol. Endocrinol. 61, T11\u2013T28 (2018).","journal-title":"J. Mol. Endocrinol."},{"key":"99124_CR31","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1210\/er.2013-1071","volume":"35","author":"P Kamenicky","year":"2014","unstructured":"Kamenicky, P., Mazziotti, G., Lombes, M., Giustina, A. & Chanson, P. Growth hormone, insulin-like growth factor-1, and the kidney: pathophysiological and clinical implications. Endocr. Rev. 35, 234\u2013281. https:\/\/doi.org\/10.1210\/er.2013-1071 (2014).","journal-title":"Endocr. Rev."},{"key":"99124_CR32","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1681\/ASN.V11112027","volume":"11","author":"J Haylor","year":"2000","unstructured":"Haylor, J. et al. JB3, an IGF-I receptor antagonist, inhibits early renal growth in diabetic and uninephrectomized rats. J. Am. Soc. Nephrol. 11, 2027\u20132035. https:\/\/doi.org\/10.1681\/ASN.V11112027 (2000).","journal-title":"J. Am. Soc. Nephrol."},{"key":"99124_CR33","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1681\/ASN.2013080859","volume":"25","author":"M Venkatareddy","year":"2014","unstructured":"Venkatareddy, M. et al. Estimating podocyte number and density using a single histologic section. J. Am. Soc. Nephrol. 25, 1118\u20131129 (2014).","journal-title":"J. Am. Soc. Nephrol."},{"key":"99124_CR34","doi-asserted-by":"publisher","DOI":"10.1136\/jclinpath-2020-207149","author":"JA Schaub","year":"2021","unstructured":"Schaub, J. A. et al. Quantitative morphometrics reveals glomerular changes in patients with infrequent segmentally sclerosed glomeruli. J. Clin. Pathol. https:\/\/doi.org\/10.1136\/jclinpath-2020-207149 (2021).","journal-title":"J. Clin. Pathol."},{"key":"99124_CR35","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1182\/blood-2005-01-0293","volume":"107","author":"E Menu","year":"2006","unstructured":"Menu, E. et al. Inhibiting the IGF-1 receptor tyrosine kinase with the cyclolignan PPP: An in vitro and in vivo study in the 5T33MM mouse model. Blood 107, 655\u2013660. https:\/\/doi.org\/10.1182\/blood-2005-01-0293 (2006).","journal-title":"Blood"},{"key":"99124_CR36","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.1681\/ASN.2005010055","volume":"16","author":"BL Wharram","year":"2005","unstructured":"Wharram, B. L. et al. Podocyte depletion causes glomerulosclerosis: Diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene. J. Am. Soc. Nephrol. 16, 2941\u20132952. https:\/\/doi.org\/10.1681\/ASN.2005010055 (2005).","journal-title":"J. Am. Soc. Nephrol."},{"key":"99124_CR37","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/ki.2011.306","volume":"81","author":"A Fukuda","year":"2012","unstructured":"Fukuda, A. et al. Angiotensin II-dependent persistent podocyte loss from destabilized glomeruli causes progression of end stage kidney disease. Kidney Int. 81, 40\u201355. https:\/\/doi.org\/10.1038\/ki.2011.306 (2012).","journal-title":"Kidney Int."},{"key":"99124_CR38","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S2213-8587(15)00368-X","volume":"4","author":"GA Knoll","year":"2016","unstructured":"Knoll, G. A. et al. Ramipril versus placebo in kidney transplant patients with proteinuria: A multicentre, double-blind, randomised controlled trial. Lancet Diabetes Endocrinol. 4, 318\u2013326. https:\/\/doi.org\/10.1016\/S2213-8587(15)00368-X (2016).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"99124_CR39","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1681\/ASN.2012080777","volume":"24","author":"HN Ibrahim","year":"2013","unstructured":"Ibrahim, H. N. et al. Angiotensin II blockade in kidney transplant recipients. J Am Soc Nephrol 24, 320\u2013327. https:\/\/doi.org\/10.1681\/ASN.2012080777 (2013).","journal-title":"J Am Soc Nephrol"},{"key":"99124_CR40","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/ncpneph0808","volume":"4","author":"C Mariat","year":"2008","unstructured":"Mariat, C. Early use of renin\u2013angiotensin\u2013aldosterone system inhibitors after renal transplantation. Nat. Clin. Pract. Nephrol. 4, 306\u2013307 (2008).","journal-title":"Nat. Clin. Pract. Nephrol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-99124-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-99124-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-99124-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T16:20:12Z","timestamp":1670084412000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-99124-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,1]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["99124"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-99124-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,1]]},"assertion":[{"value":"6 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"ASN has served on the advisory board for Care Dx. All other authors have no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19605"}}